Stockscreener 앱 받기
64.22
1.59%
-1.04
시간 외 거래:
63.50
-0.72
-1.12%
전일 마감가:
$65.26
열려 있는:
$66.57
하루 거래량:
2.16M
Relative Volume:
0.87
시가총액:
$8.01B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-15.15
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
+2.20%
1개월 성능:
+13.52%
6개월 성능:
+56.10%
1년 성능:
+211.60%
1일 변동 폭
$63.87
$66.57
1주일 범위
$61.70
$66.57
52주 변동 폭
$20.14
$68.00
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
GH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
64.22 | 8.14B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-25 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 재개 | Wells Fargo | Overweight |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
How to track smart money flows in Guardant Health Inc.Weekly Gains Report & Daily Profit Focused Screening - newser.com
Using Ichimoku Cloud for Guardant Health Inc. technicals2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025 - Yahoo Finance
CustomerThink - CustomerThink
Quantitative breakdown of Guardant Health Inc. recent movePortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
Why Guardant Health Inc. (5GH) stock stays on top picksOptions Play & AI Powered Market Entry Strategies - newser.com
Pattern recognition hints at Guardant Health Inc. upsideTake Profit & Weekly High Conviction Trade Ideas - newser.com
Is Guardant Health Inc. building a consolidation base2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com
Abel Hall LLC Invests $202,000 in Guardant Health, Inc. $GH - MarketBeat
Published on: 2025-10-09 03:21:22 - newser.com
Guardant Health's (GH) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
What drives Guardant Health Inc 5GH stock priceAnalyst Downgrades & Market Volatility Strategies - earlytimes.in
Evercore ISI Group Raises Price Target for Guardant Health (GH) to $68 | GH Stock News - GuruFocus
Evercore ISI Raises Guardant Health (NASDAQ:GH) Price Target to $68.00 - MarketBeat
Liquid Biopsy for Early Cancer Detection and Monitoring - GlobeNewswire
Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - Yahoo Finance
Is Guardant Health Inc. (5GH) stock dividend growth reliableTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Visualizing Guardant Health Inc. stock with heatmapsCPI Data & Weekly Return Optimization Plans - newser.com
What momentum shifts mean for Guardant Health Inc.Quarterly Market Review & Precise Trade Entry Recommendations - newser.com
Using economic indicators to assess Guardant Health Inc. potentialJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Guardant Health Inc Stock Analysis and ForecastMarket Liquidity Analysis & Rapid Capital Trading Plans - earlytimes.in
Shareholders in Guardant Health (NASDAQ:GH) Are in the Red If They Invested Three Years Ago - 富途牛牛
Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic - MSN
How FDA Approval of Guardant360 CDx as Companion Diagnostic Could Impact Guardant Health (GH) Investors - Yahoo Finance
Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance
How to use a screener to detect Guardant Health Inc. breakoutsTrade Risk Report & Smart Money Movement Alerts - newser.com
What Does the Market Think About Guardant Health Inc? - Sahm
Comparing Guardant Health Inc. in custom built stock radarsJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Risk adjusted return profile for Guardant Health Inc. analyzedMarket Sentiment Report & Daily Momentum Trading Reports - newser.com
Barclays Raises Price Target for Guardant Health (GH) to $70.00 | GH Stock News - GuruFocus
4,782 Shares in Guardant Health, Inc. $GH Purchased by Trivium Point Advisory LLC - MarketBeat
GCC Liquid Biopsy Market Forecast and Company Analysis - GlobeNewswire
GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex - Yahoo Finance
Sicart Associates LLC Increases Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (GH) Unveils Shield V2, Boosts Early Cancer Detection Accuracy - Insider Monkey
What drives Guardant Health Inc stock priceEx-Dividend Date Alerts & Free Take Advantage Of Momentum - earlytimes.in
Stocks making big moves yesterday: Beyond Meat, The Trade Desk, Guardant Health, PayPal, and Tilray - The Globe and Mail
Guardant Health backs lung cancer screening advocacy campaign - Mugglehead Magazine
FDA approves Guardant360 CDx as companion diagnostic for breast cancer drug - Investing.com Nigeria
Guardant Health (GH) Secures FDA Approval for Diagnostic Test - GuruFocus
Guardant Health Hosts Investor Day in NYC - MSN
FDA Approves Guardant 360 CDx With Imlunestrant in ESR1+ Breast Cancer - Targeted Oncology
Why Guardant Health (GH) Stock Is Trading Up Today - TradingView
Guardant Health (GH) Secures FDA Approval for Breast Cancer Diag - GuruFocus
FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer - Business Wire
SWS Partners Cuts Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
가든트헬스 주식 (GH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Monroe Terilyn J. | Chief People Officer |
Oct 01 '25 |
Option Exercise |
0.00 |
10,477 |
0 |
31,397 |
| Kalia Kumud | Chief Information Officer |
Oct 01 '25 |
Option Exercise |
0.00 |
10,549 |
0 |
29,713 |
| Freeman Chris | Chief Commercial Officer |
Oct 01 '25 |
Option Exercise |
0.00 |
13,550 |
0 |
63,179 |
| EAGLE CRAIG | Chief Medical Officer |
Oct 01 '25 |
Option Exercise |
0.00 |
13,859 |
0 |
51,341 |
| Chudova Darya | Chief Technology Officer |
Oct 01 '25 |
Option Exercise |
0.00 |
16,104 |
0 |
97,553 |
| Bell Michael Brian | Chief Financial Officer |
Oct 01 '25 |
Option Exercise |
0.00 |
15,181 |
0 |
59,822 |
| Talasaz AmirAli | Co-Chief Executive Officer |
Sep 30 '25 |
Option Exercise |
0.00 |
4,814 |
0 |
1,988,479 |
| Talasaz AmirAli | Co-Chief Executive Officer |
Oct 01 '25 |
Option Exercise |
0.00 |
23,997 |
0 |
2,010,036 |
| Krognes Steve E. | Director |
Sep 30 '25 |
Option Exercise |
0.00 |
154 |
0 |
18,282 |
| Eltoukhy Helmy | Co-Chief Executive Officer |
Sep 30 '25 |
Option Exercise |
0.00 |
4,814 |
0 |
2,128,313 |
0.17%
2.19%
자본화:
|
볼륨(24시간):